Company intelligence / Profile preview

Healis Therapeutics

Newport Beach, California, United Stateshealisthera.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Healis Therapeutics is developing CKDB‑501A, a botulinum toxin type A neuromodulator, as a novel treatment for major depressive disorder and other neuropsychiatric conditions. The company has reported promising results from randomized controlled trials of glabellar BoNT/A injections for MDD. Its strategic partnership with CKD Bio provides access to clinical-stage BoNT/A assets that have demonstrated non-inferiority to BOTOX® in aesthetic indications and are now being advanced into psychiatric indications through collaborations with Massachusetts General Hospital and Harvard Medical School affiliates[4][5][6][8].

Therapeutic areas: Psychiatry
Modalities: ProteinBiologicNeuromodulator (specifically Botulinum toxin type A)
Industry: Biotech

Partnerships

Massachusetts General Hospital / Harvard Medical School affiliates (clinical collaboration)[4][5]CKD Bio Corporation / Chong Kun Dang group (supply agreement & development partner)[6]

Beyond the preview

Go deeper on Healis Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Healis Therapeutics.

Explore the full profile